ArticleOpen forum infectious diseases2014

Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C.

Thomas R O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.